Literature DB >> 23098294

Cognitive impairment in euthymic major depressive disorder: a meta-analysis.

E Bora1, B J Harrison, M Yücel, C Pantelis.   

Abstract

BACKGROUND: There is evidence to suggest that cognitive deficits might persist beyond the acute stages of illness in major depressive disorder (MDD). However, the findings are somewhat inconsistent across the individual studies conducted to date. Our aim was to conduct a systematic review and meta-analysis of existing studies that have examined cognition in euthymic MDD patients.
METHOD: Following a systematic search across several publication databases, meta-analyses were conducted for 27 empirical studies that compared euthymic adult MDD patients (895 participants) and healthy controls (997 participants) across a range of cognitive domains. The influence of demographic variables and confounding factors, including age of onset and recurrent episodes, was examined.
RESULTS: Compared with healthy controls, euthymic MDD patients were characterized by significantly poorer cognitive functions. However, the magnitude of observed deficits, with the exception of inhibitory control, were generally modest when late-onset cases were excuded. Late-onset cases demonstrated significantly more pronounced deficits in verbal memory, speed of information processing and some executive functions.
CONCLUSIONS: Cognitive deficits, especially poor response inhibition, are likely to be persistent features, at least of some forms, of adult-onset MDD. More studies are necessary to examine cognitive dysfunction in remitted psychotic, melancholic and bipolar spectrum MDD. Cognitive deficits overall appear to be more common among patients with late-onset depression, supporting the theories suggesting that possible vascular and neurodegenerative factors play a role in a substantial number of these patients.

Entities:  

Mesh:

Year:  2012        PMID: 23098294     DOI: 10.1017/S0033291712002085

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  117 in total

Review 1.  Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.

Authors:  Chadi G Abdallah; Lynnette A Averill; John H Krystal
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

2.  Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness.

Authors:  Milena Radoman; Susanne S Hoeppner; Randi M Schuster; A Eden Evins; Jodi M Gilman
Journal:  Cogn Affect Behav Neurosci       Date:  2019-08       Impact factor: 3.282

3.  Early childhood depression, emotion regulation, episodic memory, and hippocampal development.

Authors:  Deanna M Barch; Michael P Harms; Rebecca Tillman; Elizabeth Hawkey; Joan L Luby
Journal:  J Abnorm Psychol       Date:  2019-01

4.  Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.

Authors:  Jan Engelmann; Stefanie Wagner; Daniel Wollschläger; Sabine Kaaden; Konrad F Schlicht; Nadine Dreimüller; Dieter F Braus; Marianne B Müller; Oliver Tüscher; Helge Frieling; André Tadić; Klaus Lieb
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-30       Impact factor: 5.270

5.  Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.

Authors:  Nikolaos Koutsouleris; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Marlene Rosen; Anne Ruef; Dominic B Dwyer; Marco Paolini; Katharine Chisholm; Joseph Kambeitz; Theresa Haidl; André Schmidt; John Gillam; Frauke Schultze-Lutter; Peter Falkai; Maximilian Reiser; Anita Riecher-Rössler; Rachel Upthegrove; Jarmo Hietala; Raimo K R Salokangas; Christos Pantelis; Eva Meisenzahl; Stephen J Wood; Dirk Beque; Paolo Brambilla; Stefan Borgwardt
Journal:  JAMA Psychiatry       Date:  2018-11-01       Impact factor: 21.596

6.  Microvascular Endothelial Function and Neurocognition Among Adults With Major Depressive Disorder.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Lana L Watkins; Benson M Hoffman; Andrew Sherwood
Journal:  Am J Geriatr Psychiatry       Date:  2018-06-28       Impact factor: 4.105

7.  Cognitive deficits specific to depression-prone smokers during abstinence.

Authors:  Rebecca Ashare; Andrew A Strasser; E Paul Wileyto; Jocelyn Cuevas; Janet Audrain-McGovern
Journal:  Exp Clin Psychopharmacol       Date:  2014-06-16       Impact factor: 3.157

8.  Differential engagement of cognitive control regions and subgenual cingulate based upon presence or absence of comorbid anxiety with depression.

Authors:  Lisanne M Jenkins; Jonathan P Stange; Katie L Bessette; Yi-Shin Chang; Samantha D Corwin; Kristy A Skerrett; Víctor G Patrón; Jon-Kar Zubieta; Natania A Crane; Alessandra M Passarotti; Daniel S Pine; Scott A Langenecker
Journal:  J Affect Disord       Date:  2018-08-01       Impact factor: 4.839

Review 9.  The association between cognitive function and subsequent depression: a systematic review and meta-analysis.

Authors:  M A Scult; A R Paulli; E S Mazure; T E Moffitt; A R Hariri; T J Strauman
Journal:  Psychol Med       Date:  2016-09-14       Impact factor: 7.723

Review 10.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.